title: Clinical usefulness of prothrombin fragment 1+2 in patients with suspected pulmonary embolism.
authors.affiliation: Department of Vascular Medicine, Academical Medical Center Amsterdam, the Netherlands. n.s.gibson@amc.uva.nl
authors.forename: Nadine S
authors.initials: NS
authors.lastname: Gibson
authors.forename: Maaike
authors.initials: M
authors.lastname: Sohne
authors.forename: Victor E A
authors.initials: VE
authors.lastname: Gerdes
authors.forename: Joost C M
authors.initials: JC
authors.lastname: Meijers
authors.forename: Harry R
authors.initials: HR
authors.lastname: Buller
mesh_terms: D015331:Cohort Studies; D005338:Fibrin Fibrinogen Degradation Products; D006801:Humans; D010446:Peptide Fragments; D011237:Predictive Value of Tests; D011516:Prothrombin; D011655:Pulmonary Embolism / Q000175:diagnosis*; D012372:ROC Curve; D012189:Retrospective Studies; D012680:Sensitivity and Specificity
chemical_list: D005338:Fibrin Fibrinogen Degradation Products; D010446:Peptide Fragments; C036309:fibrin fragment D; C045879:prothrombin fragment 1.2; D011516:Prothrombin